Free Trial

BlackRock Capital Allocation Term Trust (NYSE:BCAT) Plans Monthly Dividend of $0.27

BlackRock Capital Allocation Term Trust logo with Manufacturing background

Key Points

  • BlackRock Capital Allocation Term Trust (NYSE:BCAT) announced a monthly dividend of $0.2675 per share, with payment scheduled for October 31st to investors of record on October 15th.
  • The dividend represents an annualized yield of 21.5%, indicating high returns for investors in the trust.
  • As of the latest trading, BCAT shares opened at $14.95, with a 52-week fluctuation between $12.91 and $16.65.
  • MarketBeat previews the top five stocks to own by November 1st.

BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) declared a monthly dividend on Wednesday, October 1st. Investors of record on Wednesday, October 15th will be paid a dividend of 0.2675 per share on Friday, October 31st. This represents a c) annualized dividend and a yield of 21.5%. The ex-dividend date of this dividend is Wednesday, October 15th.

BlackRock Capital Allocation Term Trust Stock Performance

Shares of BCAT stock opened at $14.95 on Thursday. BlackRock Capital Allocation Term Trust has a 52-week low of $12.91 and a 52-week high of $16.65. The stock's 50-day moving average price is $14.92 and its 200 day moving average price is $14.75.

About BlackRock Capital Allocation Term Trust

(Get Free Report)

-

Further Reading

Dividend History for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BlackRock Capital Allocation Term Trust Right Now?

Before you consider BlackRock Capital Allocation Term Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock Capital Allocation Term Trust wasn't on the list.

While BlackRock Capital Allocation Term Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.